Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin

Biomedicine and Pharmacotherapy

Volumn 67, Issue 5, 2013, Pages 417-424

  Du, Xiao Xue ^a   Li, Yan Jing ^a   Wu, Chun Long ^a   Zhou, Jian Hua ^a   Han, Yu ^a   Sui, Hong ^a   Wei, Xiao Li ^a   Liu, Lei ^a   Huang, Peng ^a   Yuan, Heng Heng ^a   Zhang, Ting Ting ^a   Zhang, Wen Jie ^a   Xie, Rui ^a   Lang, Xiao Hui ^a   Jia, De Xin ^a   Bai, Yu Xian ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Cell cycle arrest; Dihydroartemisinin; Esophageal cancer

Indexed keywords

CASPASE 9; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; DIHYDROARTEMISININ; PROCASPASE 3; PROTEIN BAX; PROTEIN BCL XL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; AUTOPHAGY; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; HUMANS; UP-REGULATION;

EID: 84878368300     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.01.013     Document Type: Article

References (31)

1. Xu Y., Yu X., Chen Q., et al. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?. World J Surg Oncol 2012, 10:173.
2. Tran G.D., Sun X.D., Abnet C.C., et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005, 113:456-463.
3. Siegel R., Naishadham D., Jemal A. Cancer statistics 2012. CA Cancer J Clin 2012, 62:10-29.
4. Enzinger P.C., Mayer R.J. Esophageal cancer. Engl N Med 2003, 349:2241-2252.
5. Lu Y.Y., Chen T.S., Wang X.P., et al. Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques. J Biomed Opt 2010, 15:046028.
6. Noori S., Hassan Z.M. Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivo. Cell Immunol 2011, 271:67-72.
7. Hou J., Wang D., Zhang R., et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 2008, 14:5519-5530.
8. Chen H., Sun B., Wang S., et al. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest andinactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol 2010, 136:897-903.
9. Chen H., Sun B., Pan S., et al. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anticancer Drugs 2009, 20:131-140.
10. Lu J.J., Chen S.M., Zhang X.W., et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Invest New Drugs 2011, 29:1276-1283.
11. Huang X.J., Li C.T., Zhang W.P., et al. Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells. Pharmacology 2008, 82:1-9.
12. Huang X.J., Ma Z.Q., Zhang W.P., et al. Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells. J Pharm Pharmacol 2007, 59:849-856.
13. He Q., Shi J., Shen X.L., et al. Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis inhuman prostate cancer cells. Cancer Biol Ther 2010, 9:819-824.
14. Morrissey C., Gallis B., Solazzi J.W., et al. Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs 2010, 21:423-432.
15. Reiners J.J., Agostinis P., Berg K., et al. Assessing autophagy in the context of photodynamic therapy. Autophagy 2010, 6:7-18.
16. Kroemer G., Galluzzi L., Vandenabeele P., et al. Classification of cell death: Recommendations of the nomenclature committee on cell death. Cell Death Differ 2009, 16:3-11.
17. Feril L.B., Kondo T., Cui Z.G., et al. Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett 2005, 221:145-152.
18. Gustafsson A.B., Gottlieb R.A. Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 2007, 292:C45-C51.
19. Wakabayashi K., Saito H., Ebinuma H., et al. Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period. Oncol Rep 2000, 7:285-288.
20. Adams J.M., Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001, 26:61-66.
21. Schwarz C.S., Evert B.O., Seyfried J., et al. Overexpression of bcl-2 results in reduction of cytochrome c content and inhibition of complex I activity. Biochem Biophys Res Commun 2001, 280:1021-1027.
22. Jiao Y., Ge C.M., Meng Q.H., et al. Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 2007, 28:1045-1056.
23. Nam W., Tak J., Ryu J.K., et al. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 2007, 29:335-340.
24. Lin X., Tang M., Tao Y., et al. Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle. Cancer Sci 2012, 103:993-999.
25. Sherr C.J., Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes 2004, 18:2699-2711.
26. Wang S.J., Gao Y., Chen H., et al. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 2010, 293:99-108.
27. Ji Y., Zhang Y.C., Pei L.B., et al. Anti-tumor effects of dihydroartemisinin on human osteosarcoma. Mol Cell Biochem 2011, 351:99-108.
28. Lu C.H., Liu Y.W., Hua S.C., et al. Autophagy induction of reversine on human follicular thyroid cancer cells. Biomed Pharmacother 2012, 66:642-647.
29. Zhuang W., Long L., Zheng B., et al. Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy. Cancer Sci 2012, 103:684-690.
30. Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011, 17:654-666.
31. Kessel D., Vicente M.G., Reiners J.J. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 2006, 38:482-488.